Phase I Study of Intraventricular Administration of Rituximab in Patients With Recurrent CNS and Intraocular Lymphoma
Top Cited Papers
- 10 April 2007
- journal article
- hematologic malignancies
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 25 (11) , 1350-1356
- https://doi.org/10.1200/jco.2006.09.7311
Abstract
Purpose We previously determined that intravenous administration of rituximab results in limited penetration of this agent into the leptomeningeal space. Systemic rituximab does not reduce the risk...Keywords
This publication has 23 references indexed in Scilit:
- Gene expression and angiotropism in primary CNS lymphomaBlood, 2006
- Report of an International Workshop to Standardize Baseline Evaluation and Response Criteria for Primary CNS LymphomaJournal of Clinical Oncology, 2005
- Lymphocyte Transformation by Pim-2 Is Dependent on Nuclear Factor-κB ActivationCancer Research, 2004
- The unique transcriptome through day 3 of human preimplantation developmentHuman Molecular Genetics, 2004
- Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray ExperimentsStatistical Applications in Genetics and Molecular Biology, 2004
- The PIM-2 Kinase Phosphorylates BAD on Serine 112 and Reverses BAD-induced Cell DeathJournal of Biological Chemistry, 2003
- The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitorGenes & Development, 2003
- ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profileBlood, 2003
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- R: A Language for Data Analysis and GraphicsJournal of Computational and Graphical Statistics, 1996